​

Kestra Medical Technologies (KMTS) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChartTranscripts

KMTS Stock Forecast

Kestra Medical Technologies (KMTS) stock forecast, based on 4 Wall Street analysts, predicts a 12-month average price target of $28.00, with a high of $30.00 and a low of $24.00. This represents a 43.52% increase from the last price of $19.51.

KMTS Stock Rating

Kestra Medical Technologies stock's rating consensus is Buy, based on 4 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 3 Buy (75.00%), 1 Hold (25.00%), 0 Sell (0.00%), and 0 Strong Sell (0.00%).

Buy
Total 4 0 1 3 Strong Sell Sell Hold Buy Strong Buy

KMTS Price Target Upside V Benchmarks

TypeNameUpside
StockKestra Medical Technologies43.52%
SectorHealthcare Stocks 15.45%
IndustryMedical Instruments & Supplies Stocks26.45%

Price Target Trends

1M3M12M
# Anlaysts--6
Avg Price Target--$27.33
Last Closing Price$19.51$19.51$19.51
Upside/Downside--40.08%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Apr, 26151--7
Mar, 26151--7
Feb, 26151--7
Jan, 26151--7
Dec, 25141--6
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Jan 16, 2026Goldman Sachs$24.00$22.984.44%23.01%
Jan 09, 2026Goldman Sachs$27.00$26.651.31%38.39%
Dec 13, 2025Goldman Sachs$25.00$26.22-4.65%28.14%
Dec 12, 2025Stifel Nicolaus$30.00$26.5213.12%53.77%
Dec 12, 2025Wells Fargo$28.00$24.9712.13%43.52%
Dec 12, 2025Matt O'BrienPiper Sandler$30.00$24.9720.14%53.77%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Jan 09, 2026Goldman SachsNeutralNeutralhold
Dec 13, 2025Goldman SachsNeutralNeutralhold
Dec 12, 2025Wells FargoOverweightOverweighthold
Dec 12, 2025Piper SandlerOverweightOverweighthold

Financial Forecast

EPS Forecast

Apr 25 Apr 26 Apr 27 Apr 28
Apr 25Apr 26Apr 27Apr 28
Reported----
Avg Forecast$-2.20$-1.89$-1.48$-0.79
High Forecast$-1.73$-1.68$-1.45$-0.78
Low Forecast$-3.51$-2.02$-1.51$-0.80
Surprise %----

Revenue Forecast

$50M $80M $110M $140M $170M $200M Apr 25 Apr 26 Apr 27 Apr 28
Apr 25Apr 26Apr 27Apr 28
Reported----
Avg Forecast$58.25M$82.90M$126.91M$187.90M
High Forecast$58.34M$83.77M$128.24M$189.87M
Low Forecast$58.10M$82.26M$125.92M$186.44M
Surprise %----

Net Income Forecast

$-200M $-160M $-120M $-80M $-40M $0 Apr 25 Apr 26 Apr 27 Apr 28
Apr 25Apr 26Apr 27Apr 28
Reported----
Avg Forecast$-95.07M$-97.77M$-73.31M$-39.20M
High Forecast$-85.69M$-83.22M$-71.82M$-38.73M
Low Forecast$-173.86M$-100.06M$-74.80M$-39.66M
Surprise %----

KMTS Forecast FAQ

Is Kestra Medical Technologies stock a buy?

Kestra Medical Technologies stock has a consensus rating of Buy, based on 4 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 3 Buy, 1 Hold, 0 Sell, and 0 Strong Sell, reflecting a consensus that Kestra Medical Technologies is a favorable investment for most analysts.

What is Kestra Medical Technologies's price target?

Kestra Medical Technologies's price target, set by 4 Wall Street analysts, averages $28 over the next 12 months. The price target range spans from $24 at the low end to $30 at the high end, suggesting a potential 43.52% change from the previous closing price of $19.51.

How does Kestra Medical Technologies stock forecast compare to its benchmarks?

Kestra Medical Technologies's stock forecast shows a 43.52% upside, outperforming the average forecast for the healthcare stocks sector (15.45%) and outperforming the medical instruments & supplies stocks industry (26.45%).

What is the breakdown of analyst ratings for Kestra Medical Technologies over the past three months?

  • April 2026: 14.29% Strong Buy, 71.43% Buy, 14.29% Hold, 0% Sell, 0% Strong Sell.
  • March 2026: 14.29% Strong Buy, 71.43% Buy, 14.29% Hold, 0% Sell, 0% Strong Sell.
  • February 2026: 14.29% Strong Buy, 71.43% Buy, 14.29% Hold, 0% Sell, 0% Strong Sell.

What is Kestra Medical Technologies’s EPS forecast?

Kestra Medical Technologies's average annual EPS forecast for its fiscal year ending in April 2025 is $-2.2, marking a 0% decrease from the reported - in 2024. Estimates for the following years are $-1.89 in 2026, $-1.48 in 2027, and $-0.79 in 2028.

What is Kestra Medical Technologies’s revenue forecast?

Kestra Medical Technologies's average annual revenue forecast for its fiscal year ending in April 2025 is $58.25M, reflecting a 0% decrease from the reported - in 2024. The forecast for 2026 is $82.9M, followed by $126.91M for 2027, and $187.9M for 2028.

What is Kestra Medical Technologies’s net income forecast?

Kestra Medical Technologies's net income forecast for the fiscal year ending in April 2025 stands at $-95.069M, representing a 0% decrease from the reported - in 2024. Projections indicate $-97.767M in 2026, $-73.31M in 2027, and $-39.199M in 2028.